Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237


One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL.

Blood. 1977 Apr;49(4):511-33.


Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia.

Graw RG Jr, Lohrmann HP, Bull MI, Decter J, Herzig GP, Bull JM, Leventhal BG, Yankee RA, Herzig RH, Krueger GR, Bleyer WA, Buja ML, McGinniss MH, Alter HJ, Whang-Peng J, Gralnick HR, Kirkpatrick CH, Henderson ES.

Transplant Proc. 1974 Dec;6(4):349-54. No abstract available.


Bone marrow transplantation in acute leukemia using intensive chemoradiotherapy (SCARI--UCLA).

Gale RP, Feig S, Opelz G, Territo M, Young L, Sarna G, Fahey J, Cline MJ.

Transplant Proc. 1976 Dec;8(4):611-6. No abstract available.


ABO blood group system and bone marrow transplantation.

Gale RP, Feig S, Ho W, Falk P, Rippee C, Sparkes R.

Blood. 1977 Aug;50(2):185-94.


Bone marrow transplantation in man.

Cline MJ, Gale RP, Stiehm ER, Opelz G, Young LS, Feig SA, Fahey JL.

Ann Intern Med. 1975 Nov;83(5):691-708. Review.


T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.

Papadopoulos EB, Carabasi MH, Castro-Malaspina H, Childs BH, Mackinnon S, Boulad F, Gillio AP, Kernan NA, Small TN, Szabolcs P, Taylor J, Yahalom J, Collins NH, Bleau SA, Black PM, Heller G, O'Reilly RJ, Young JW.

Blood. 1998 Feb 1;91(3):1083-90.


Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.

Champlin R, Ho W, Gajewski J, Feig S, Burnison M, Holley G, Greenberg P, Lee K, Schmid I, Giorgi J, et al.

Blood. 1990 Jul 15;76(2):418-23.


Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.

Bassan R, Raimondi R, Lerede T, D'emilio A, Buelli M, Borleri G, Personeni A, Bellavita P, Rodeghiero F, Barbui T.

Haematologica. 1998 Jul;83(7):627-35.


T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.

Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA.

Blood. 1999 Jul 15;94(2):434-41. Erratum in: Blood 2000 Feb 15;95(4):1137.


CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.

Soiffer RJ, Fairclough D, Robertson M, Alyea E, Anderson K, Freedman A, Bartlett-Pandite L, Fisher D, Schlossman RL, Stone R, Murray C, Freeman A, Marcus K, Mauch P, Nadler L, Ritz J.

Blood. 1997 Apr 15;89(8):3039-47.


Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)

Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Löffler H, Hunter A, Russell NH.

Blood. 1995 Mar 15;85(6):1666-72.


Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.

De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.

Bone Marrow Transplant. 1993;12 Suppl 3:S2-6.


Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.

Robin M, Guardiola P, Dombret H, Baruchel A, Esperou H, Ribaud P, Devergie A, Gluckman E, Socié G.

Bone Marrow Transplant. 2003 May;31(10):877-87.


Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia.

Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Forman SJ, Schmidt GM, Scott EP, Spruce WE, Turner MA, Wolf JL.

N Engl J Med. 1980 May 8;302(19):1041-6.


Allogeneic bone marrow transplantation: relation between chimaerism and immunity.

Vossen J.

Verh K Acad Geneeskd Belg. 1998;60(2):111-43; discussion 143-5. Review.


Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?

Mehta J, Powles R, Sirohi B, Treleaven J, Kulkarni S, Saso R, Tait D, Singhal S.

Bone Marrow Transplant. 2002 May;29(10):853-9.


CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.

Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.

Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.


Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR Jr, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, Rowlings PA, Van Hoef ME, Gratwohl A.

Blood. 2000 Jun 15;95(12):3702-9.


Allogeneic marrow grafts in man using cyclophosphamide.

Santos GW, Sensenbrenner LL, Burke PJ, Mullins GM, Anderson PN, Tutschka PJ, Braine HG, Davis TE, Humphrey RL, Abeloff MD, Bias WB, Borgaonkar DS, Slavin RE.

Transplant Proc. 1974 Dec;6(4):345-8. No abstract available.


Supplemental Content

Support Center